Scarcity of atrial fibrillation in a traditional African population: A community-based study

BMC Cardiovascular Disorders

Volumn 14, Issue , 2014, Pages

  Koopman, Jacob J E ^a   van Bodegom, David ^a,b   Westendorp, Rudi G J ^a,b   Jukema, Johan W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Leyden Academy on Vitality and Ageing   (Netherlands)

Author keywords

Africa; Aging; Atrial fibrillation; Electrocardiography; Inflammation; Lifestyle

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; AUTACOID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; IL6 PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; ELECTROCARDIOGRAM; FEMALE; GHANA; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEREDITY; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RURAL POPULATION; WAIST CIRCUMFERENCE; ANALYSIS; ATRIAL FIBRILLATION; BLACK PERSON; BLOOD; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; ETHNOLOGY; HEALTH; MIDDLE AGED; PATHOPHYSIOLOGY; VERY ELDERLY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; FEMALE; GHANA; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIFE STYLE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL HEALTH; WAIST CIRCUMFERENCE;

EID: 84904275103     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-87     Document Type: Article

References (49)

1. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res 2014, 114:1453-1468.
2. Go AS, Hylek EM, Phillips KA, Chang YC, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study. J Am Med Assoc 2001, 285:2370-2375.
3. Magnani JW, Rienstra M, Lin H, Sinner MF, Lubitz SA, McManus DD, Dupuis J, Ellinor PT, Benjamin EJ. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation 2011, 124:1982-1993.
4. Lip GYH, Tse HF, Lane DA. Atrial fibrillation. Lancet 2012, 379:648-661.
5. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011, 123:1501-1508.
6. Smith JG, Platonov PG, Hedblad B, Engström G, Melander O. Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010, 25:95-102.
7. Guo Y, Lip GYH, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012, 60:2263-2270.
8. Hernandez MB, Asher CR, Hernandez AV, Novaro GM. African American race and prevalence of atrial fibrillation: a meta-analysis. Cardiol Res Pract 2012, 2012:275624.
9. Lipworth L, Okafor H, Mumma MT, Edwards TL, Roden DM, Blot WJ, Darbar D. Race-specific impact of atrial fibrillation risk factors in blacks and whites in the Southern community cohort study. Am J Cardiol 2012, 110(11):1637-1642.
10. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocr Rev 2008, 29:777-822.
11. Dewhurst MJ, Adams PC, Gray WK, Dewhurst F, Orega GP, Chaote P, Walker RW. Strikingly low prevalence of atrial fibrillation in elderly Tanzanians. J Am Geriatr Soc 2012, 60:1135-1140.
12. Ntep-Gweth M, Zimmermann M, Meiltz A, Kingue S, Ndobo P, Urban P, Bloch A. Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon. Europace 2010, 12:482-487.
13. Soliman EZ, Alonso A, Goff DC. Atrial fibrillation and ethnicity: the known, the unknown and the paradox. Future Cardiol 2009, 5:547-556.
14. van Bodegom D, May L, Kuningas M, Kaptijn R, Thomése F, Meij JJ, Amankwa J, Westendorp RGJ. Socio-economic status by rapid appraisal is highly correlated with mortality risks in rural Africa. Trans R Soc Trop Med Hyg 2009, 103:795-800.
15. Ghana Statistical Service Ghana Living Standards Survey: Report of the Fifth Round (GLSS 5) 2008, Ghana: Accra, Ghana Statistical Service.
16. Ghana Poverty Reduction Strategy An Agenda for Growth and Prosperity. Volume I: Analysis and Policy Statement 2003, Location unknown, Ghana Poverty Reduction Strategy.
17. Ghana Health Service Upper East Regional Health Administration Annual Report 2004 2005, Ghana: Accra, Ghana Health Service.
18. Meij JJ, de Craen AJM, Agana J, Plug D, Westendorp RGJ. Low-cost interventions accelerate epidemiological transition in Upper East Ghana. Trans R Soc Trop Med Hyg 2009, 103:173-178.
19. Meij JJ, van Bodegom D, Ziem JB, Amankwa J, Polderman AM, Kirkwood TBL, de Craen AJM, Zwaan BJ, Westendorp RGJ. Quality-quantity trade-off of human offspring under adverse environmental conditions. J Evol Biol 2009, 22:1014-1023.
20. Boef AGC, May L, van Bodegom D, van Lieshout L, Verweij JJ, Maier AB, Westendorp RGJ, Eriksson UK. Parasitic infections and immune function: effect of helminth infections in a malaria endemic area. Immunobiol 2012, 10:6-11.
21. Koopman JJE, van Bodegom D, Jukema JW, Westendorp RGJ. Risk of cardiovascular disease in a traditional African population with a high infectious load: a population-based study. PLoS One 2012, 7:e46855.
22. National Heart, Lung, and Blood Institute, National Institutes of Health The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7) 2004, 12. Bethesda, MD: NIH Publication No 04-5230, National Heart, Lung, and Blood Institute, National Institutes of Health.
23. May L, van den Biggelaar AHJ, van Bodegom D, Meij JJ, de Craen AJM, Amankwa J, Frölich M, Kuningas M, Westendorp RGJ. Adverse environmental conditions influence age-related innate immune responsiveness. Immun Ageing 2009, 6:7.
24. National Health and Nutrition Examination Survey (NHANES) National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC) 1999-2000, http://wwwn.cdc.gov/nchs/nhanes/search/nhanes99_00.aspx, National Health and Nutrition Examination Survey (NHANES).
25. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol Ser A Biol Sci Med Sci 1997, 52:M201-M208.
26. Schrire V. The racial incidence of the less common forms of heart disease at Groote Schuur Hospital, Cape Town, 1952-61. S Afr Med J 1964, 38:598-601.
27. Rizzon P, Page PF, Snyman HW. Abnormalities of conduction and arrhythmias in the most common cardiopathies amongst the South African Bantu. Cardiologia 1967, 51:15-21.
28. Connor M, Rheeder P, Bryer A, Meredith M, Beukes M, Dubb A, Fritz V. The South African stroke risk in general practice study. S Afr Med J 2005, 95:334-339.
29. Coulibaly I, Anzouan-Kacou JB, Konin KC, Kouadio SC, Abouo-N'Dori R. [Atrial fibrillation: epidemiological data from the Cardiology Institute in Abidjan, Côte d'Ivoire]. Med Trop (Mars) 2010, 70:371-374.
30. Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, Stewart S. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the heart of Soweto study. Heart 2010, 96:1878-1882.
31. Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D, Dzudie A, Kouam CK, Suliman A, Schrueder N, Yonga G, Ba SA, Maru F, Alemayehu B, Edwards C, Davison BA, Cotter G, Sliwa K. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the Sub-Saharan Africa survey of heart failure. Arch Intern Med 2012, 172:1-9.
32. Boef AGC, May L, van Bodegom D, Kuningas M, Eriksson UK, Westendorp RGJ. The influence of genetic variation on innate immune activation in an environment with high infectious pressure. Genes Immun 2012, 13:103-108.
33. Kuningas M, May L, Tamm R, van Bodegom D, van den Biggelaar AHJ, Meij JJ, Frölich M, Ziem JB, Suchiman HED, Metspalu A, Slagboom PE, Westendorp RGJ. Selection for genetic variation inducing pro-inflammatory responses under adverse environmental conditions in a Ghanaian population. PLoS One 2009, 4:e7795.
34. Eriksson UK, van Bodegom D, May L, Boef AGC, Westendorp RGJ. Low C-reactive protein levels in a traditional West-African population living in a malaria endemic area. PLoS One 2013, 8:e70076.
35. Marott SCW, Nordestgaard BG, Zacho J, Friberg J, Jensen GB, Tybjærg-Hansen A, Benn M. Does elevated C-reactive protein increase atrial fibrillation risk?. J Am Coll Cardiol 2010, 56:789-795.
36. Marcus GM, Smith LM, Ordovas K, Scheinman MM, Kim AM, Badhwar N, Lee RJ, Tseng ZH, Lee BK, Olgin JE. Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm 2010, 7:149-154.
37. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the heart and soul study. Am Heart J 2008, 155:303-309.
38. Ellinor PT, Low A, Patton KK, Shea MA, MacRae CA. C-Reactive protein in lone atrial fibrillation. Am J Cardiol 2006, 97:1346-1350.
39. Asghar O, Alam U, Hayat SA, Aghamohammadzadeh R, Heagerty AM, Malik RA. Obesity, diabetes and atrial fibrillation: epidemiology, mechanisms and interventions. Curr Cardiol Rev 2012, 8:253-264.
40. Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008, 52:306-313.
41. Tanner RM, Baber U, Carson AP, Voeks J, Brown TM, Soliman EZ, Howard VJ, Muntner P. Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] study). Am J Cardiol 2011, 108:227-232.
42. Chamberlain AM, Agarwal SK, Folsom AR, Soliman EZ, Chambless LE, Crow R, Ambrose M, Alonso A. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011, 107:85-91.
43. Prineas RJ, Soliman EZ, Howard G, Howard VJ, Cushman M, Zhang ZM, Moy CS. The sensitivity of the method used to detect atrial fibrillation in population studies affects group-specific prevalence estimates: ethnic and regional distribution of atrial fibrillation in the REGARDS study. J Epidemiol 2009, 19:177-181.
44. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, Arking DE, Müller-Nurasyid M, Krijthe BP, Lubitz SA, Bis JC, Chung MK, Dörr M, Ozaki K, Roberts JD, Smith JG, Pfeufer A, Sinner MF, Lohman K, Ding J, Smith NL, Smith JD, Rienstra M, Rice KM, Van Wagoner DR, Magnani JW, Wakili R, Clauss S, Rotter JI, Steinbeck G, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012, 44:670-675.
45. Smith JG, Almgren P, Engström G, Hedblad B, Platonov PG, Newton-Cheh C, Melander O. Genetic polymorphisms for estimating risk of atrial fibrillation: a literature-based meta-analysis. J Intern Med 2012, 272:573-582.
46. Bryc K, Auton A, Nelson MR, Oksenberg JR, Hauser SL, Williams S, Froment A, Bodo JM, Wambebe C, Tishkoff SA, Bustamante CD. Genome-wide patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci U S A 2010, 107:786-791.
47. Delaney JT, Jeff JM, Brown NJ, Pretorius M, Okafor HE, Darbar D, Roden DM, Crawford DC. Characterization of genome-wide association-identified variants for atrial fibrillation in African Americans. PLoS One 2012, 7:e32338.
48. Marcus GM, Alonso A, Peralta CA, Lettre G, Vittinghoff E, Lubitz SA, Fox ER, Levitzky YS, Mehra R, Kerr KF, Deo R, Sotoodehnia N, Akylbekova M, Ellinor PT, Paltoo DN, Soliman EZ, Benjamin EJ, Heckbert SR. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation 2010, 122:2009-2015.
49. Engelaer FM, Koopman JJE, van Bodegom D, Eriksson UK, Westendorp RGJ. Determinants of epidemiologic transition in rural Africa: the role of socioeconomic status and drinking water source. Trans R Soc Trop Med Hyg 2014, 108:372-379.